Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 276

1.

Prevalence of metabolic syndrome among ethnic groups in China.

Qin X, Qiu L, Tang G, Tsoi MF, Xu T, Zhang L, Qi Z, Zhu G, Cheung BMY.

BMC Public Health. 2020 Mar 6;20(1):297. doi: 10.1186/s12889-020-8393-6.

2.

Vancomycin-associated acute kidney injury in Hong Kong in 2012-2016.

Qin X, Tsoi MF, Zhao X, Zhang L, Qi Z, Cheung BMY.

BMC Nephrol. 2020 Feb 3;21(1):41. doi: 10.1186/s12882-020-1704-4.

3.

Comparative cardiovascular risk in users versus non-users of xanthine oxidase inhibitors and febuxostat versus allopurinol users.

Ju C, Lai RWC, Li KHC, Hung JKF, Lai JCL, Ho J, Liu Y, Tsoi MF, Liu T, Cheung BMY, Wong ICK, Tam LS, Tse G.

Rheumatology (Oxford). 2019 Dec 24. pii: kez576. doi: 10.1093/rheumatology/kez576. [Epub ahead of print]

PMID:
31873735
4.

High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.

Wong YK, Cheung CYY, Tang CS, Hai JSH, Lee CH, Lau KK, Au KW, Cheung BMY, Sham PC, Xu A, Lam KSL, Tse HF.

Cardiovasc Diabetol. 2019 Dec 17;18(1):171. doi: 10.1186/s12933-019-0974-2.

5.

Osler Centenary Papers: Osler: the towering genius who disdained a beaten path.

Cheung BMY.

Postgrad Med J. 2019 Dec;95(1130):636. doi: 10.1136/postgradmedj-2019-137016. No abstract available.

PMID:
31754053
6.

The lipid-lowering effect of once-daily soya drink fortified with phytosterols in normocholesterolaemic Chinese: a double-blind randomized controlled trial.

Chau YP, Cheng YC, Sing CW, Tsoi MF, Cheng VK, Lee GK, Cheung CL, Cheung BMY.

Eur J Nutr. 2019 Oct 23. doi: 10.1007/s00394-019-02119-w. [Epub ahead of print]

PMID:
31642984
7.

Three-component non-invasive risk score for undiagnosed diabetes in Chinese people: Development, validation and longitudinal evaluation.

Woo YC, Gao B, Lee CH, Fong CH, Lui DT, Ming J, Wang L, Yeung KM, Cheung BM, Lam TH, Janus E, Ji Q, Lam KS.

J Diabetes Investig. 2020 Mar;11(2):341-348. doi: 10.1111/jdi.13144. Epub 2019 Oct 1.

8.

Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis.

Fei Y, Tsoi MF, Cheung BMY.

Cardiovasc Diabetol. 2019 Aug 28;18(1):112. doi: 10.1186/s12933-019-0916-z.

9.

Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study.

Lau WCY, Douglas IJ, Wong ICK, Smeeth L, Lip GYH, Leung WK, Siu CW, Cheung BMY, Mok MTC, Chan EW.

Heart Rhythm. 2020 Jan;17(1):33-40. doi: 10.1016/j.hrthm.2019.07.034. Epub 2019 Aug 1.

PMID:
31377423
10.

25-Hydroxyvitamin D and the risk of incident diabetes in Hong Kong Chinese.

Leung RY, Cheung BM, Tan KC, Kung AW, Cheung CL.

Public Health Nutr. 2019 Jun 6:1-7. doi: 10.1017/S1368980019000582. [Epub ahead of print]

PMID:
31169100
11.

Serum metabolomic profiling and its association with 25-hydroxyvitamin D.

Leung RYH, Li GHY, Cheung BMY, Tan KCB, Kung AWC, Cheung CL.

Clin Nutr. 2020 Apr;39(4):1179-1187. doi: 10.1016/j.clnu.2019.04.035. Epub 2019 May 11.

PMID:
31160086
12.

Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention of Recurrent Cardiovascular Events in a Real-World Cohort of Post-Acute Myocardial Infarction Patients.

Huang D, Cheng YY, Wong YA, Yung SA, Tam CF, Chan KK, Lam CS, Yiu KH, Hai JJ, Lau CP, Chan EW, Chiang CE, Wong KL, Cheung T, Cheung BM, Feng YQ, Tan N, Chen JY, Yue WS, Hu HX, Chen L, Tse HF, Chan PH, Siu CW.

Circ J. 2019 Mar 25;83(4):809-817. doi: 10.1253/circj.CJ-18-0308. Epub 2019 Feb 22.

13.

Evaluation of GDF15 as a therapeutic target of cardiometabolic diseases in human: A Mendelian randomization study.

Cheung CL, Tan KCB, Au PCM, Li GHY, Cheung BMY.

EBioMedicine. 2019 Mar;41:85-90. doi: 10.1016/j.ebiom.2019.02.021. Epub 2019 Feb 13.

14.

Never too old for statin treatment?

Cheung BMY, Lam KSL.

Lancet. 2019 Feb 2;393(10170):379-380. doi: 10.1016/S0140-6736(18)32263-3. No abstract available.

15.

Clinical Therapeutics in Hong Kong.

Cheung BMY, Yau HKC.

Clin Ther. 2019 Mar;41(3):592-597. doi: 10.1016/j.clinthera.2019.01.002. Epub 2019 Jan 29.

PMID:
30709611
16.

Fast-tracking acute stroke care in China: Shenzhen Stroke Emergency Map.

Ren L, Li C, Li W, Zeng Y, Ye S, Li Z, Feng H, Lei Z, Cai J, Hu S, Sui Y, Liu Q, Cheung BMY.

Postgrad Med J. 2019 Jan;95(1119):46-47. doi: 10.1136/postgradmedj-2018-136192. Epub 2019 Jan 29.

17.

Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.

Cheung BMY.

N Engl J Med. 2019 Jan 17;380(3):299-300. doi: 10.1056/NEJMc1816189. No abstract available.

PMID:
30653282
18.

Determining the Optimal Systolic Blood Pressure for Hypertensive Patients: A Network Meta-analysis.

Fei Y, Tsoi MF, Cheung BMY.

Can J Cardiol. 2018 Dec;34(12):1581-1589. doi: 10.1016/j.cjca.2018.08.013. Epub 2018 Aug 10.

PMID:
30414702
19.

Dietary Intake of Anti-Oxidant Vitamins A, C, and E Is Inversely Associated with Adverse Cardiovascular Outcomes in Chinese-A 22-Years Population-Based Prospective Study.

Lee CH, Chan RSM, Wan HYL, Woo YC, Cheung CYY, Fong CHY, Cheung BMY, Lam TH, Janus E, Woo J, Lam KSL.

Nutrients. 2018 Nov 4;10(11). pii: E1664. doi: 10.3390/nu10111664.

20.

Age-Biomarkers-Clinical Risk Factors for Prediction of Cardiovascular Events in Patients With Coronary Artery Disease.

Wong YK, Cheung CYY, Tang CS, Au KW, Hai JSH, Lee CH, Lau KK, Cheung BMY, Sham PC, Xu A, Lam KSL, Tse HF.

Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2519-2527. doi: 10.1161/ATVBAHA.118.311726.

PMID:
30354221
21.

Corrigendum to "A Phase I, Single- and Multiple-dose Study to Evaluate the Pharmacokinetics of Elbasvir and Grazoprevir in Healthy Chinese Participants" [Clinical Therapeutics 40 (2018) 719-732].

Cheung TT, Chiu JWY, Yuen MF, Lam KSL, Cheung BMY, Feng HP, Yeh WW, Wang J, Li W, Zhao XM, Wang Z, Mu S.

Clin Ther. 2018 Sep;40(9):1618. doi: 10.1016/j.clinthera.2018.06.005. Epub 2018 Aug 25. No abstract available.

PMID:
30153946
22.

Medical student research: is it necessary and beneficial?

Cheung BMY.

Postgrad Med J. 2018 Jun;94(1112):317. doi: 10.1136/postgradmedj-2018-135834. No abstract available.

PMID:
29853556
23.

Network meta-analysis of cardiovascular outcomes in randomized controlled trials of new antidiabetic drugs.

Fei Y, Tsoi MF, Kumana CR, Cheung TT, Cheung BMY.

Int J Cardiol. 2018 Mar 1;254:291-296. doi: 10.1016/j.ijcard.2017.12.039. Epub 2017 Dec 20.

PMID:
29277321
24.

Measuring non-polyaminated lipocalin-2 for cardiometabolic risk assessment.

Yang K, Deng HB, Man AWC, Song E, Zhang J, Luo C, Cheung BMY, Yuen KY, Jensen PS, Irmukhamedov A, Elie AGIM, Vanhoutte PM, Xu A, De Mey JGR, Wang Y.

ESC Heart Fail. 2017 Nov;4(4):563-575. doi: 10.1002/ehf2.12183. Epub 2017 Jun 27.

25.

Fetuin-A levels and risk of type 2 diabetes mellitus: a systematic review and meta-analysis.

Guo VY, Cao B, Cai C, Cheng KK, Cheung BMY.

Acta Diabetol. 2018 Jan;55(1):87-98. doi: 10.1007/s00592-017-1068-9. Epub 2017 Nov 11. Review.

PMID:
29127490
26.

Validation of the diabetes screening tools proposed by the American Diabetes Association in an aging Chinese population.

Woo YC, Lee CH, Fong CHY, Tso AWK, Cheung BMY, Lam KSL.

PLoS One. 2017 Sep 14;12(9):e0184840. doi: 10.1371/journal.pone.0184840. eCollection 2017.

27.

Hypertension: a weighty problem in children.

Cheung BMY.

Postgrad Med J. 2017 Nov;93(1105):647. doi: 10.1136/postgradmedj-2016-134341. Epub 2017 Aug 20. No abstract available.

PMID:
28823997
28.

Towards a Transparent, Credible, Evidence-Based Decision-Making Process of New Drug Listing on the Hong Kong Hospital Authority Drug Formulary: Challenges and Suggestions.

Wong CKH, Wu O, Cheung BMY.

Appl Health Econ Health Policy. 2018 Feb;16(1):5-14. doi: 10.1007/s40258-017-0339-5.

PMID:
28702874
29.

No lead is better than a little lead.

Cheung BMY, Cheung TT.

Postgrad Med J. 2017 Sep;93(1103):512. doi: 10.1136/postgradmedj-2017-134916. Epub 2017 Jun 29. No abstract available.

PMID:
28663353
30.

Fake peer review - too good to be true.

Cheung BMY.

Postgrad Med J. 2017 Aug;93(1102):498. doi: 10.1136/postgradmedj-2016-134506. Epub 2017 Jun 7. No abstract available.

PMID:
28592588
31.

Absolute benefits of empagliflozin in type 2 diabetes: a game changer?

Kumana CR, Tan KCB, Cheung BMY.

Postgrad Med J. 2017 Jul;93(1101):373-375. doi: 10.1136/postgradmedj-2016-134741. Epub 2017 Apr 22. No abstract available.

PMID:
28433975
32.

2016 Consensus statement on prevention of atherosclerotic cardiovascular disease in the Hong Kong population.

Cheung BM, Cheng CH, Lau CP, Wong CK, Ma RC, Chu DW, Ho DH, Lee KL, Tse HF, Wong AS, Yan BP, Yan VW.

Hong Kong Med J. 2017 Apr;23(2):191-201. doi: 10.12809/hkmj165045.

33.

An Exome-Chip Association Analysis in Chinese Subjects Reveals a Functional Missense Variant of GCKR That Regulates FGF21 Levels.

Cheung CYY, Tang CS, Xu A, Lee CH, Au KW, Xu L, Fong CHY, Kwok KHM, Chow WS, Woo YC, Yuen MMA, Cherny SS, Hai J, Cheung BMY, Tan KCB, Lam TH, Tse HF, Sham PC, Lam KSL.

Diabetes. 2017 Jun;66(6):1723-1728. doi: 10.2337/db16-1384. Epub 2017 Apr 6.

34.

The Potential Role of Fibroblast Growth Factor 21 in Lipid Metabolism and Hypertension.

Huang Z, Xu A, Cheung BMY.

Curr Hypertens Rep. 2017 Apr;19(4):28. doi: 10.1007/s11906-017-0730-5. Review.

PMID:
28337713
35.

Optimal vitamin D status and its relationship with bone and mineral metabolism in Hong Kong Chinese.

Leung RY, Cheung BM, Nguyen US, Kung AW, Tan KC, Cheung CL.

Bone. 2017 Apr;97:293-298. doi: 10.1016/j.bone.2017.01.030. Epub 2017 Jan 24.

PMID:
28130180
36.

Randomized controlled trial of the effect of phytosterols-enriched low-fat milk on lipid profile in Chinese.

Cheung CL, Ho DK, Sing CW, Tsoi MF, Cheng VK, Lee GK, Ho YN, Cheung BM.

Sci Rep. 2017 Jan 24;7:41084. doi: 10.1038/srep41084.

37.

Incidence and risk estimate of drug-induced agranulocytosis in Hong Kong Chinese. A population-based case-control study.

Sing CW, Wong IC, Cheung BM, Chan JC, Chu JK, Cheung CL.

Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):248-255. doi: 10.1002/pds.4156. Epub 2017 Jan 13.

PMID:
28083886
38.

Serum 25-hydroxyvitamin D and the risk of stroke in Hong Kong Chinese.

Leung RY, Han Y, Sing CW, Cheung BM, Wong IC, Tan KC, Kung AW, Cheung CL.

Thromb Haemost. 2017 Jan 5;117(1):158-163. doi: 10.1160/TH16-07-0551. Epub 2016 Oct 27.

PMID:
27786341
39.

Continual Decrease in Blood Lead Level in Americans: United States National Health Nutrition and Examination Survey 1999-2014.

Tsoi MF, Cheung CL, Cheung TT, Cheung BM.

Am J Med. 2016 Nov;129(11):1213-1218. doi: 10.1016/j.amjmed.2016.05.042. Epub 2016 Jun 21.

40.

Septic Pulmonary Embolism Requiring Critical Care: Clinicoradiological Spectrum, Causative Pathogens and Outcomes.

Chou DW, Wu SL, Chung KM, Han SC, Cheung BM.

Clinics (Sao Paulo). 2016 Oct 1;71(10):562-569. doi: 10.6061/clinics/2016(10)02.

41.

Exome-chip association analysis reveals an Asian-specific missense variant in PAX4 associated with type 2 diabetes in Chinese individuals.

Cheung CY, Tang CS, Xu A, Lee CH, Au KW, Xu L, Fong CH, Kwok KH, Chow WS, Woo YC, Yuen MM, Hai JS, Jin YL, Cheung BM, Tan KC, Cherny SS, Zhu F, Zhu T, Thomas GN, Cheng KK, Jiang CQ, Lam TH, Tse HF, Sham PC, Lam KS.

Diabetologia. 2017 Jan;60(1):107-115. Epub 2016 Oct 15.

PMID:
27744525
42.

Optimal Cut-Offs of Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) to Identify Dysglycemia and Type 2 Diabetes Mellitus: A 15-Year Prospective Study in Chinese.

Lee CH, Shih AZ, Woo YC, Fong CH, Leung OY, Janus E, Cheung BM, Lam KS.

PLoS One. 2016 Sep 22;11(9):e0163424. doi: 10.1371/journal.pone.0163424. eCollection 2016.

43.

Serum fibroblast growth factor 21 is a superior biomarker to other adipokines in predicting incident diabetes.

Woo YC, Lee CH, Fong CH, Xu A, Tso AW, Cheung BM, Lam KS.

Clin Endocrinol (Oxf). 2017 Jan;86(1):37-43. doi: 10.1111/cen.13229. Epub 2016 Sep 29.

PMID:
27611701
44.

Burden of upper gastrointestinal symptoms in patients prescribed dabigatran for stroke prevention.

Chan PH, Hai JJ, Huang D, Ho MH, Chan EW, Cheung BM, Chan AO, Wong IC, Tse HF, Hung IF, Siu CW.

SAGE Open Med. 2016 Aug 4;4:2050312116662414. doi: 10.1177/2050312116662414. eCollection 2016.

45.

Gastrointestinal haemorrhage in atrial fibrillation patients: impact of quality of anticoagulation control.

Chan PH, Li WH, Hai JJ, Chan KH, Tse HF, Cheung BM, Chan EW, Wong IC, Leung WK, Hung IF, Lip GY, Siu CW.

Eur Heart J Cardiovasc Pharmacother. 2015 Oct;1(4):265-72. doi: 10.1093/ehjcvp/pvv032. Epub 2015 Aug 11.

PMID:
27532451
46.

Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: Meta-analysis of randomized controlled trials.

Fei Y, Tsoi MF, Cheung TT, Cheung BM.

Int J Cardiol. 2016 Oct 1;220:895-900. doi: 10.1016/j.ijcard.2016.06.070. Epub 2016 Jun 23.

PMID:
27400191
47.

Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses.

Li X, Tse VC, Lau WC, Cheung BM, Lip GY, Wong IC, Chan EW.

PLoS One. 2016 Jun 30;11(6):e0157129. doi: 10.1371/journal.pone.0157129. eCollection 2016.

48.

Non-vitamin K Oral Anticoagulants Versus Warfarin for Patients with Atrial Fibrillation: Absolute Benefit and Harm Assessments Yield Novel Insights.

Kumana CR, Cheung BM, Siu DC, Tse HF, Lauder IJ.

Cardiovasc Ther. 2016 Apr;34(2):100-6. doi: 10.1111/1755-5922.12173. Review.

49.

Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese.

Tang CS, Zhang H, Cheung CY, Xu M, Ho JC, Zhou W, Cherny SS, Zhang Y, Holmen O, Au KW, Yu H, Xu L, Jia J, Porsch RM, Sun L, Xu W, Zheng H, Wong LY, Mu Y, Dou J, Fong CH, Wang S, Hong X, Dong L, Liao Y, Wang J, Lam LS, Su X, Yan H, Yang ML, Chen J, Siu CW, Xie G, Woo YC, Wu Y, Tan KC, Hveem K, Cheung BM, Zöllner S, Xu A, Eugene Chen Y, Jiang CQ, Zhang Y, Lam TH, Ganesh SK, Huo Y, Sham PC, Lam KS, Willer CJ, Tse HF, Gao W.

Nat Commun. 2015 Dec 22;6:10206. doi: 10.1038/ncomms10206.

50.

Diabetes is associated with increased risks of low lean mass and slow gait speed when peripheral artery disease is present.

Cheung CL, Lam KS, Cheung BM.

J Diabetes Complications. 2016 Mar;30(2):306-11. doi: 10.1016/j.jdiacomp.2015.11.015. Epub 2015 Nov 14.

PMID:
26684167

Supplemental Content

Loading ...
Support Center